Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
folic acid (1 trial)
capecitabine (xeloda) (1 trial)
gimeracil (2 trials)
oteracil (2 trials)
s-1 (2 trials)
tegafur (2 trials)
gemcitabine (gemzar) (1 trial)
Biliary Tract Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (7 total)